Popular headlines from a resilient industry in a year rife with challenges.

Following a scientific forum hosted by KSU, the collective data presented on non-hereditary DCM points to neither a cause nor an increase in the number of occurrences.

The market research firm has highlighted opportunities for cat product proliferation, ingredient and sourcing claims, private label brand growth and other opportune areas for the industry to grow.

A peer-reviewed article from a team of veterinary professionals and nutritionists with BSM Partners determined more comprehensive research that considers several confounding factors is needed.

The companies are conducting a study of more than 1,000 dogs to better understand the canine heart disease.

Understanding best practices for formulating with these sustainable, multi-functional and cost-effective ingredients.

Animal food industry players posed complex questions to Dr. Steven Solomon following his presentation at the 2019 Feed and Pet Food Joint Conference.

Several of the 16 brands called out in the FDA’s recent report have responded to the confusion, concern and, in some cases, blame among some pet owners.

The agency has released its third update on an investigation into the potential link between certain pet food diets and canine dilated cardiomyopathy.

As the FDA continues to investigate cases of DCM, pet food formulators try to determine what, if any, implications the investigation has on ingredient categories.